Every announcement Wanbury has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Price
₹262.05
Market Cap
₹916.31
Revenue TTM
₹652.67
P/E (TTM)
16.4×
Sector 45.68×
Reference data from Trendlyne, as of the most recent story. Not a valuation or a recommendation.
Wanbury Limited Secures EDQM Approval for Rivaroxaban API and Key USFDA Clearances
Wanbury Limited receives EDQM approval for Rivaroxaban API and USFDA DMF clearances for Paroxetine HCI and Metformin HCI, targeting the EU and US pha…
Wanbury Ltd Submits DMFs for Global API Launch; Patalganga Unit Receives Zero Observations
Wanbury Ltd expands global API reach with DMF submissions for Diphenhydramine HCl and Paroxetine HCl. Patalganga facility clears Korea MFDS audit wit…
Track Wanbury in real time
ALFA Finder watches NSE & BSE filings 24/7 and alerts you the moment Wanbury files something material.
Start Free — 15-day trial